Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Pediatric Blood & Cancer
|
August 26, 2006
Development and research in idiopathic thrombocytopenic purpura: an inflammatory and autoimmune disorder
Paul Imbach
Paediatric Drugs
|
December 9, 2003
Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options
Paul Imbach
Swiss Medical Weekly
|
June 2, 2012
Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases. A historical review
Paul Imbach
Annals of Hematology
|
April 21, 2010
Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
Thomas Kühne, Paul Imbach
Journal of Pediatric Hematology/Oncology
|
December 12, 2003
Local and cultural aspects of childhood idiopathic thrombocytopenic purpura: a summary of statements from the 12 countries worldwide
Paul Imbach, Sherri Zimmerman
Journal of Pediatric Hematology/Oncology
|
December 12, 2003
New developments in idiopathic thrombocytopenic purpura (ITP): cooperative, prospective studies by the Intercontinental Childhood ITP Study Group
Paul Imbach, Thomas Kühne, Sherri Zimmerman
Pediatric Blood & Cancer
|
August 26, 2006
Idiopathic thrombocytopenic purpura (ITP): is there a genetic predisposition?
Johannes R Rischewski, Paul Imbach, Michael Paulussen, et al.
Frontiers in Medicine
|
July 12, 2021
Understanding Immune Thrombocytopenia: Looking Out of the Box
Alexandra Schifferli, Franco Cavalli, Bertrand Godeau, et al.
The Journal of Pediatrics
|
November 15, 2003
A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group
Thomas Kühne, George R Buchanan, Sherri Zimmerman, et al.
Hematology (Amsterdam, Netherlands)
|
September 25, 2010
Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia
Tadeusz Robak, Claudia Mainau, Barbara Pyringer, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Pediatric Blood & Cancer
|
August 26, 2006
Development and research in idiopathic thrombocytopenic purpura: an inflammatory and autoimmune disorder
Paul Imbach
Paediatric Drugs
|
December 9, 2003
Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options
Paul Imbach
Swiss Medical Weekly
|
June 2, 2012
Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases. A historical review
Paul Imbach
Annals of Hematology
|
April 21, 2010
Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
Thomas Kühne, Paul Imbach
Journal of Pediatric Hematology/Oncology
|
December 12, 2003
Local and cultural aspects of childhood idiopathic thrombocytopenic purpura: a summary of statements from the 12 countries worldwide
Paul Imbach, Sherri Zimmerman
Journal of Pediatric Hematology/Oncology
|
December 12, 2003
New developments in idiopathic thrombocytopenic purpura (ITP): cooperative, prospective studies by the Intercontinental Childhood ITP Study Group
Paul Imbach, Thomas Kühne, Sherri Zimmerman
Pediatric Blood & Cancer
|
August 26, 2006
Idiopathic thrombocytopenic purpura (ITP): is there a genetic predisposition?
Johannes R Rischewski, Paul Imbach, Michael Paulussen, et al.
Frontiers in Medicine
|
July 12, 2021
Understanding Immune Thrombocytopenia: Looking Out of the Box
Alexandra Schifferli, Franco Cavalli, Bertrand Godeau, et al.
The Journal of Pediatrics
|
November 15, 2003
A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group
Thomas Kühne, George R Buchanan, Sherri Zimmerman, et al.
Hematology (Amsterdam, Netherlands)
|
September 25, 2010
Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia
Tadeusz Robak, Claudia Mainau, Barbara Pyringer, et al.
Page
of 3